Skip to main content

Senior Director, Regulatory Affairs Strategy

Senior Director, Regulatory Affairs Strategy
Organization: Genma
Location: Plainsboro, NJ
Date Posted: 10/02/2024

At Genmab, we’re committed to building extraordinary futures together by developing antibody products and pioneering therapies that change the lives of patients and the future of cancer treatment and serious diseases. From our people who are caring, candid, and impact-driven to our business, which is innovative and rooted in science, we believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

### The Role

Genmab is looking for an experienced and passionate leader to be a part of our Global Regulatory Affairs (GRA) organization.

In this role, the regulatory leader will be primarily responsible for the development of US regulatory strategies and serve as the Global Regulatory Strategist to advance Genmab’s portfolio of development and marketed drugs. This individual will provide strategic input, ensure operational execution of US submission activities, and work collaboratively with Regional Regulatory Strategists with responsibilities ex-US. The individual will interface directly with the US FDA as the primary contact for assigned programs. Importantly, the chosen candidate will manage and mentor a group of Regulatory Affairs strategists.

As a key member of the Regulatory Affairs leadership team, you will play a critical role in ensuring compliance with global regulations and driving the growth of our company. The ideal candidate will have a strong background in regulatory affairs, exceptional leadership skills, and a passion for making a difference in the lives of patients. This position is based in our Princeton, NJ office with onsite presence 60% of the time and reports to the Head of Regulatory Affairs.

### Responsibilities:

Key responsibilities include but are not limited to:

– Act as the US/Global Regulatory Leader (GRL) for assigned projects and be responsible for the development, implementation, and maintenance of US/global regulatory strategies across all stages of development.
– Lead, manage, and mentor a team of regulatory professionals to ensure timely and successful submissions of drug applications to global regulatory agencies.
– Evaluate regulatory risk and recommend mitigation strategies to ensure optimal regulatory success.
– Provide expertise and guidance on global regulatory requirements, guidelines, and changes that may impact the company’s products.
– Prepare and review regulatory submissions, including INDs and (s)BLAs, for accuracy, completeness, and compliance with regulations and guidelines.
– Evaluate various regulatory mechanisms to optimize product development (e.g., orphan drug designation, breakthrough therapy designation, Fast Track, accelerated approval, compassionate use, pediatric plans, diversity action plans) and ensure they are implemented, if applicable.
– Consult with senior management to develop and communicate regulatory strategies and recommendations for products and programs.
– Interact with US FDA for assigned projects. The US/GRL will lead and/or participate in meetings with FDA and other health authorities as appropriate.
– Build strong relationships with key external stakeholders, including regulatory agencies, professional societies, and key opinion leaders.
– Drive continuous improvement initiatives to enhance regulatory processes, systems, and capabilities.

### Requirements:

– BSc or MSc level degree preferably within the life sciences (PharmD, PhD, or MD preferred)
– Minimum of 10 years of experience within Regulatory Affairs (Oncology experience preferred)
– Direct interaction/negotiation skills with regulatory authorities (e.g., FDA, EMA)
– A broad knowledge of development and life-cycle management is preferred
– Strong strategic skills, including the ability to make complex decisions and support difficult positions
– Solid knowledge and understanding of global and US regulations and the US pharmaceutical commercial landscape
– Experience with preparation and submission of IND, (s)NDA/BLA to US FDA
– Experience with labeling and PMC/PMR negotiations with US FDA
– Ability to work well within cross-functional teams
– Strong communication skills – both oral and written
– Cultural awareness and respect for diversity
– Unquestionable ethics, professional integrity, and personal values consistent with the Genmab values

For US-based candidates, the proposed salary band for this position is as follows:

$206,250.00 – $343,750.00

The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Certain positions are eligible for additional forms of compensation, such as bonuses.

### About You

– You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment.
– You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving.
– You are a generous collaborator who can work in teams with diverse backgrounds.
– You are determined to do and be your best and take pride in enabling the best work of others on the team.
– You are not afraid to grapple with the unknown and be innovative.
– You have experience working in a fast-growing, dynamic company (or a strong desire to).
– You work hard and are not afraid to have a little fun while doing so.

### Locations

Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

### About Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative, and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, resulting in a proprietary pipeline that includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.

Our commitment to diversity, equity, and inclusion

We are committed to fostering workplace diversity at all levels of the company and we believe it is essential for our continued success. No applicant shall be discriminated against or treated unfairly because of their race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age, disability, or genetic information. Learn more about our commitments on our website.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website https://www.genmab.com/privacy.

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.

Learn more here

Earn a certificate with the Council! Start your journey today.

Washington, D.C. | Nov. 21, 2024

More News & Resources

«
Slide Deck

September 24, 2024

Post Type: Highlight: Featured Featured Weight: 1
Popular Weight:
Slide Deck

July 15, 2024

Post Type: Highlight: Featured Featured Weight: 1
Popular Weight:
Article

July 1, 2024

Post Type: Highlight: Featured, Articles Featured Weight: 1
Popular Weight:
Article

June 18, 2024

Post Type: Highlight: Featured, Articles Featured Weight: 1
Popular Weight:
Article

May 15, 2024

Post Type: Highlight: Featured, Articles Featured Weight: 1
Popular Weight:
Article

April 24, 2024

Post Type: Highlight: Featured, Articles Featured Weight: 1
Popular Weight:
Article

November 16, 2023

Post Type: Highlight: Featured, Articles Featured Weight: 1
Popular Weight:
Article

November 16, 2023

Post Type: Highlight: Featured, Articles Featured Weight: 1
Popular Weight:
Article

November 16, 2023

Post Type: Highlight: Featured, Articles Featured Weight: 1
Popular Weight:
Article

October 25, 2023

Post Type: Highlight: Featured, Articles Featured Weight: 1
Popular Weight:
»
Featured Event

Is your organization prepared to adapt its social impact initiatives based on who is elected, from the President all the way down-ballot? Navigate post-election shifts at STRIDE this November.

Washington, D.C. | November 21